AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity
Molecules · 2025-05-15 · 30 (10) · 2167
DOI: 10.3390/molecules30102167 ↗At a glance
Journal article in Molecules, published online on 2025-05-15. Written by Ewa Ciszkowicz and 11 co-authors. Institution: Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszów University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Po…. Major MEDLINE topics: Anti-Bacterial Agents, Fibroblasts, Cell Movement, Elapid Venoms. Cited 10 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: Minister of Science and Higher Education Republic of Poland.
Abstract (original language)
The treatment of proctological conditions, including hemorrhoids, anal fissures, and perianal abscesses, is often complicated by bacterial infections, particularly those involving multidrug-resistant Escherichia coli. This study presents the synthesis, characterization, and biological evaluation of the newly designed synthetic peptide AMPEC4, inspired by cytotoxin 5 from Naja ashei snake venom. AMPEC4 demonstrated potent antimicrobial properties with MIC values of 100 and 200 µg/mL, effectively inhibiting biofilm formation (up to 84%) and eradicating the pre-formed biofilm by up to 35%. The antibacterial activity of AMPEC4 was further supported by a membrane permeabilization assay, demonstrating its capacity to disrupt bacterial membrane integrity in a dose-dependent manner. Furthermore, AMPEC4 significantly promoted fibroblast migration, a critical step in tissue regeneration, while exhibiting notable biocompatibility, as evidenced by the absence of hemolytic, cytotoxic, and genotoxic effects. By addressing both infection control and tissue regeneration, AMPEC4 represents a promising therapeutic strategy for managing chronic wounds, particularly in the challenging environment of the anorectal region. Its ability to target Escherichia coli reference and clinical strains while accelerating the wound-healing process underscores its potential for future clinical applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszów University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Poland.
- Doctoral School of the Rzeszów University of Technology, al. Powstańców Warszawy 12, 35-959 Rzeszów, Poland.
- Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
- Department of Analytical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
ORCID profiles: Ewa Ciszkowicz, Andrzej Łyskowski, Anna Nieczaj, Konrad K Hus, Karol Sikora, Damian Neubauer, Aleksandra Bocian
Funding
- Minister of Science and Higher Education Republic of Poland
Cite
APA
Ciszkowicz, E., Miłoś, A., Łyskowski, A., Buczkowicz, J., Nieczaj, A., Lecka-Szlachta, K., Hus, K. K., Sikora, K., Neubauer, D., Bauer, M., Kamysz, W., & Bocian, A. (2025). AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity. Molecules, 30(10), 2167. https://doi.org/10.3390/molecules30102167
Vancouver
Ciszkowicz E, Miłoś A, Łyskowski A, Buczkowicz J, Nieczaj A, Lecka-Szlachta K, et al. AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity. Molecules. 2025;30(10):2167. doi:10.3390/molecules30102167
BibTeX
@article{Ciszkowicz2025,
author = {Ciszkowicz, Ewa and Miłoś, Anna and Łyskowski, Andrzej and Buczkowicz, Justyna and Nieczaj, Anna and Lecka-Szlachta, Katarzyna and Hus, Konrad K and Sikora, Karol and Neubauer, Damian and Bauer, Marta and Kamysz, Wojciech and Bocian, Aleksandra},
title = {AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity},
journal = {Molecules},
year = {2025},
volume = {30},
number = {10},
pages = {2167},
doi = {10.3390/molecules30102167}
}
EUVIMED